Literature DB >> 19679694

Increasing proportions of advanced pulmonary tuberculosis reported in the United States: are delays in diagnosis on the rise?

Ryan Maclaren Wallace1, J Steve Kammerer, Michael F Iademarco, Sandy P Althomsons, Carla A Winston, Thomas R Navin.   

Abstract

RATIONALE: Delays in the diagnosis of tuberculosis (TB) can result in progression to advanced disease. Patients with pulmonary TB and advanced disease are more likely to transmit disease and fail treatment.
OBJECTIVES: To examine clinical, epidemiological, and geographic factors associated with advanced pulmonary TB to further understanding of delayed diagnosis and transmission.
METHODS: Pulmonary tuberculosis cases in persons older than 15 years of age reported to the U.S. National Tuberculosis Surveillance System with advanced disease (cavitation on chest radiograph and acid-fast bacilli smear-positive sputum result) were compared with those without advanced disease using trend and binomial regression analysis.
MEASUREMENTS AND MAIN RESULTS: There were 35,584 cases of advanced pulmonary tuberculosis (APT) and 125,077 cases of non-APT reported from 1993 through 2006. Proportions of pulmonary TB cases with APT increased from 18.5% in 1993 to 26.1% in 2006, and the increase in the proportion of APT was most notable for national TB rates below 6.6 per 100,000. At the county level, the association between APT and low TB incidence has grown incrementally since 2000. The proportion of APT increased greatest among whites (65.4%), the employed (63.3%), and the U.S. born (59.2%). The prevalence of APT was 44% greater among persons with multidrug-resistant TB compared with those without it.
CONCLUSIONS: This study highlights the need for TB diagnosis at early stages of the disease to minimize APT and decrease the risk of transmission. Additional efforts should concentrate on reducing time to treatment initiation in low-incidence areas and among groups traditionally seen as being at low risk for TB disease.

Entities:  

Mesh:

Year:  2009        PMID: 19679694     DOI: 10.1164/rccm.200901-0059OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  19 in total

1.  Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in California.

Authors:  Ritu Banerjee; Jennifer Allen; S-Y Grace Lin; Janice Westenhouse; Ed Desmond; Gisela F Schecter; Cheryl Scott; Ann Raftery; Sundari Mase; James P Watt; Jennifer Flood
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

2.  Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

Authors:  Eleanor E Friedman; Hazel D Dean; Wayne A Duffus
Journal:  Public Health Rep       Date:  2018-06-06       Impact factor: 2.792

3.  Delayed tuberculosis diagnosis and costs of contact investigations for hospital exposure: New York City, 2010-2014.

Authors:  Ana M Kelly; John F D'Agostino; Lilibeth V Andrada; Jianfang Liu; Elaine Larson
Journal:  Am J Infect Control       Date:  2017-02-16       Impact factor: 2.918

4.  Delayed and Unreported Drug-Susceptibility Testing Results in the US National Tuberculosis Surveillance System, 1993-2014.

Authors:  Jefferson Michael Jones; Lori R Armstrong
Journal:  Public Health Rep       Date:  2017-06-06       Impact factor: 2.792

5.  Molecular surveillance for large outbreaks of tuberculosis in the United States, 2014-2018.

Authors:  Kala M Raz; Sarah Talarico; Sandy P Althomsons; J Steve Kammerer; Lauren S Cowan; Maryam B Haddad; Clinton J McDaniel; Jonathan M Wortham; Anne Marie France; Krista M Powell; James E Posey; Benjamin J Silk
Journal:  Tuberculosis (Edinb)       Date:  2022-08-09       Impact factor: 2.973

6.  Area-level socioeconomic disadvantage and severe pulmonary tuberculosis: U.S., 2000-2008.

Authors:  Eyal Oren; Masahiro Narita; Charles Nolan; Jonathan Mayer
Journal:  Public Health Rep       Date:  2013 Mar-Apr       Impact factor: 2.792

7.  Decline in tuberculosis among Mexico-born persons in the United States, 2000-2010.

Authors:  Brian J Baker; Carla D Jeffries; Patrick K Moonan
Journal:  Ann Am Thorac Soc       Date:  2014-05

8.  Evaluation of underreporting tuberculosis in Central Italy by means of record linkage.

Authors:  Lorenza Melosini; Umberto Vetrano; Federico L Dente; Michele Cristofano; Mauro Giraldi; Luciano Gabbrielli; Federica Novelli; Ferruccio Aquilini; Laura Rindi; Francesco Menichetti; Giulia Freer; Pierluigi L Paggiaro
Journal:  BMC Public Health       Date:  2012-06-21       Impact factor: 3.295

9.  Delay from symptom onset to treatment start among tuberculosis patients in England, 2012-2015.

Authors:  M G Loutet; C Sinclair; N Whitehead; C Cosgrove; M K Lalor; H L Thomas
Journal:  Epidemiol Infect       Date:  2018-06-20       Impact factor: 4.434

10.  Tuberculosis Outbreak Associated With Delayed Diagnosis and Long Infectious Periods in Rural Arkansas, 2010-2018.

Authors:  Sarah M Labuda; Clinton J McDaniel; Amish Talwar; Anthwan Braumuller; Sarah Parker; Stephanie McGaha; Carolynne Blissett; Jonathan M Wortham; Leonard Mukasa; Rebekah J Stewart
Journal:  Public Health Rep       Date:  2021-03-17       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.